Gremlin1 is a therapeutically targetable FGFR1 ligand that regulates lineage plasticity and castration resistance in prostate cancer

Chaping Cheng(Shanghai Jiao Tong University), Jinming Wang(Shanghai Jiao Tong University), Penghui Xu(Shanghai Jiao Tong University), Kai Zhang(Shanghai Jiao Tong University), Zhixiang Xin(Shanghai Jiao Tong University), Huifang Zhao(Shanghai Jiao Tong University), Zhongzhong Ji(Shanghai Jiao Tong University), Man Zhang(Shanghai Jiao Tong University), Deng Wang(Shanghai Jiao Tong University), Yuman He(Shanghai Jiao Tong University), Na Jing(Shanghai Jiao Tong University), Liancheng Fan(Shanghai Jiao Tong University), Kaiyuan Liu(Shanghai Jiao Tong University), Fei Li(Chinese Academy of Sciences), Chengcheng Liu(Shanghai Jiao Tong University), Yiming Gong(Shanghai Jiao Tong University), Suli Cui(Bioscience (China)), Zhe Sun(Bioscience (China)), Di Sun(Bioscience (China)), Xinlai Yao(Bioscience (China)), Hongjun Li(Bioscience (China)), Jian Zhang(Zhengzhou University), Pengcheng Zhang(Chinese Academy of Sciences), Baijun Dong(Shanghai Jiao Tong University), Wei Xue(Shanghai Jiao Tong University), Xueming Qian(Bioscience (China)), Wei‐Qiang Gao(Shanghai Jiao Tong University), Helen He Zhu(Shanghai Jiao Tong University)
Nature Cancer
May 27, 2022
Cited by 66

Abstract


Related Papers

No related papers found

Powered by citation graph analysis